These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10066070)

  • 1. Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1.
    Cariou S; Catzavelos C; Slingerland JM
    Breast Cancer Res Treat; 1998; 52(1-3):29-41. PubMed ID: 10066070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.
    Tsihlias J; Kapusta L; Slingerland J
    Annu Rev Med; 1999; 50():401-23. PubMed ID: 10073286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.
    Catzavelos C; Bhattacharya N; Ung YC; Wilson JA; Roncari L; Sandhu C; Shaw P; Yeger H; Morava-Protzner I; Kapusta L; Franssen E; Pritchard KI; Slingerland JM
    Nat Med; 1997 Feb; 3(2):227-30. PubMed ID: 9018244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
    Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
    Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas.
    Lau R; Grimson R; Sansome C; Tornos C; Moll UM
    Int J Oncol; 2001 Jan; 18(1):17-23. PubMed ID: 11115534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27 deregulation in breast cancer: prognostic significance and implications for therapy.
    Alkarain A; Jordan R; Slingerland J
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):67-80. PubMed ID: 15082919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.
    Harvat BL; Seth P; Jetten AM
    Oncogene; 1997 May; 14(17):2111-22. PubMed ID: 9160891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers.
    Sgambato A; Migaldi M; Faraglia B; Garagnani L; Romano G; De Gaetani C; Ferrari P; Capelli G; Trentini GP; Cittadini A
    Cancer Res; 1999 Jul; 59(13):3245-50. PubMed ID: 10397272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
    Gillett CE; Smith P; Peters G; Lu X; Barnes DM
    J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27 expression as a prognostic factor of breast cancer in Taiwan.
    Chu JS; Huang CS; Chang KJ
    Cancer Lett; 1999 Jul; 141(1-2):123-30. PubMed ID: 10454252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
    Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
    Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
    J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the cdk inhibitor p27 and its deregulation in cancer.
    Slingerland J; Pagano M
    J Cell Physiol; 2000 Apr; 183(1):10-7. PubMed ID: 10699961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
    Ohtani M; Isozaki H; Fujii K; Nomura E; Niki M; Mabuchi H; Nishiguchi K; Toyoda M; Ishibashi T; Tanigawa N
    Cancer; 1999 Apr; 85(8):1711-8. PubMed ID: 10223564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
    Sgambato A; Cittadini A; Faraglia B; Weinstein IB
    J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
    Barbareschi M
    Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.